Healthcare News

PALO ALTO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today...

Proposed $1.0 million Convertible Debenture and concurrent $500,000 Private Placement Intended to Support Near-Term Operations Board and Management Enhancements Strengthen Governance and Capital...

NESS ZIONA, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies...

DALLAS and FORT WORTH, Texas, Jan. 27, 2026 (GLOBE NEWSWIRE) -- U.S. Neurology Associates (USNA), a physician services organization dedicated to enhancing community-based neurology care, today...

EXERCICE 2025, CONFIRMATION DE LA TRANSFORMATION STRATEGIQUE Progression du chiffre d’affaires annuel de 9% à 168 M€Déploiement de la stratégie du Groupe : Produits propriétaires : 35% du Chiffre...

FISCAL YEAR 2025, CONFIRMATION OF STRATEGIC TRANSFORMATION 9% increase in annual revenue to €168 millionDeployment of the Group's strategy: Proprietary products: 35% of revenueInternationalization:...

Patterson Veterinary has relaunched NaVetor cloud software after acquiring full rights in 2025.

Worcester, Massachusetts, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST), a diversified innovation company with operations spanning eco-friendly products and collectibles...

Halo Pharma to become a stand-alone Drug Product CDMO.

Boca Raton, FL, Jan. 27, 2026 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, presents the following letter to investors from David Moss,...